Tagged aronora

Press Release

Aronora Secures Investment From New York Blood Center

 Aronora is Revolutionizing Blood Clot Treatment with Groundbreaking Innovations Read More
Aronora CEO Named National Academy of Inventors Fellow
Press Release

Aronora CEO Named National Academy of Inventors Fellow

 Aronora co-founder and CEO Dr. Erik Tucker has been elected as Fellow of the National Academy of Inventors (NAI) Read More
Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting
Press Release

Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting

 Presentation to include clinical data from a phase 2 study of Gruticibart (AB023), a factor XI-targeted antibody being developed for the treatment and prevention of thrombosis and inflammation Read More
Aronora Announces Clinical Data to Be Presented at the 63rd American Society of Hematology Annual Meeting
Press Release

Aronora Announces Clinical Data to Be Presented at the 63rd American Society of Hematology Annual Meeting

 Presentation to include clinical data from Aronora's phase 2 study of AB002, a first-in-class protein C activator enzyme that is being developed for the treatment and prevention of thrombotic and inflammatory diseases. Read More
Aronora Reports Positive Topline Data From Phase 2 Study of AB023 in Hemodialysis Patients
Press Release

Aronora Reports Positive Topline Data From Phase 2 Study of AB023 in Hemodialysis Patients

 AB023 reduces dialyzer clotting compared to placebo during heparin-free dialysis, and continues to be safe and well tolerated Read More
Aronora Announces Clinical Data to Be Presented at the 62nd American Society of Hematology Annual Meeting
Press Release

Aronora Announces Clinical Data to Be Presented at the 62nd American Society of Hematology Annual Meeting

 Presentation to include clinical data from Aronora's phase 2 study of AB023, a factor XI-targeted antibody that is being developed for the treatment and prevention of thrombosis and inflammation. Read More
Aronora's New Blood Clot Treatment Receives FDA Fast Track Designation
Press Release

Aronora's New Blood Clot Treatment Receives FDA Fast Track Designation

 Enzyme that selectively targets blood clots has received FDA Fast Track designation, allowing for expedited clinical development Read More